Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed director Quarterly results
|
ENANTA PHARMACEUTICALS INC (ENTA)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/15/2019 |
GN
| Factors of Influence in 2019, Key Indicators and Opportunity within BCE, Nektar Therapeutics, Hormel Foods, Enanta Pharmaceuticals, MongoDB, and Regal Beloit — New Research Emphasizes Economic Growth |
10/26/2018 |
GN
| Report: Developing Opportunities within Assured Guaranty, Potbelly, Enanta Pharmaceuticals, Seagate Technology, Ctrip.com International, and CyberArk Software — Future Expectations, Projections Moving into 2018 |
09/25/2018 |
GN
| Recent Analysis Shows Enanta Pharmaceuticals, Multi-Color, Otter Tail, Franklin Resources, CubeSmart, and EnPro Industries Market Influences — Renewed Outlook, Key Drivers of Growth |
05/29/2018 |
GN
| Factors of Influence in 2018, Key Indicators and Opportunity within Assembly Biosciences, MGP Ingredients, Globant S.A, 8point3 Energy Partners LP, Flexion Therapeutics, and Enanta Pharmaceuticals — New Research Emphasizes Economic Growth |
02/06/2018 |
GN
| Recent Analysis Shows Daktronics, Haynes International, Envestnet, Calpine, Enanta Pharmaceuticals, and FCB Financial Market Influences — Renewed Outlook, Key Drivers of Growth |
|
|